Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AMI 25

Known as: AMI-25, AMI25 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Abstract. A variety of parenterally administered iron oxides have been developed for contrast-enhanced MRI of the liver. Two… Expand
  • table 1
Highly Cited
1996
Highly Cited
1996
PURPOSE To assess AMI-25- versus gadolinium-enhanced magnetic resonance (MR) imaging in the differential diagnosis of liver… Expand
Highly Cited
1995
Highly Cited
1995
  • C. W. Jung
  • Magnetic resonance imaging
  • 1995
  • Corpus ID: 42576183
The surface properties of the active ingredients in AMI colloidal, superparamagnetic iron oxide magnetic resonance (MR) contrast… Expand
Highly Cited
1994
Highly Cited
1994
PURPOSE To evaluate the ability of magnetic resonance (MR) imaging enhanced with AMI-25 to depict and characterize hepatic tumors… Expand
Highly Cited
1990
Highly Cited
1990
An ultrasmall superparamagnetic iron oxide (USPIO) preparation was developed that is small enough to migrate across the capillary… Expand
Highly Cited
1990
Highly Cited
1990
We have applied a superparamagnetic iron oxide formulation (AMI‐25, Advanced Magnetics, Inc., Cambridge, MA) to image the… Expand
Highly Cited
1990
Highly Cited
1990
Previous studies of AMI-25, a particulate iron oxide magnetic resonance contrast agent, imaged liver tumors 1 or more hours after… Expand
Highly Cited
1989
Highly Cited
1989
The pharmacokinetics (distribution, metabolism, bioavailability, excretion) and toxicity (acute and subacute toxicity… Expand
Highly Cited
1989
Highly Cited
1989
This study was designed to evaluate superparamagnetic iron oxide (AMI-25) as a contrast agent for MR to distinguish normal… Expand
Highly Cited
1988
Highly Cited
1988
Superparamagnetic iron oxide (AMI-25), a reticuloendothelial cell-specific contrast agent for magnetic resonance (MR) imaging… Expand